PPG Reports 2024 Sales Decline to USD 15.845 Billion Amidst Market Challenges and Strategic Restructuring
PPG Industries recently disclosed its 2024 annual report, revealing a net sales total of approximately USD 15.845 billion, marking a 2% decline from the previous year. This decrease is primarily attributed to lower sales volumes, adverse foreign exchange impacts, and asset divestitures. Despite a downturn in demand for automotive OEM coatings, industrial coatings, and architectural coatings in Europe, the company experienced record sales in aerospace coatings, bolstering overall performance.
The pre-tax profit stood at USD 1.852 billion, an increase of USD 162 million year-over-year, driven by reduced raw material costs and savings from restructuring, although offset by inflation in indirect costs and declining sales volumes. PPG reported USD 1.4 billion in operating cash flow, demonstrating resilience amid a challenging economic environment.
Looking ahead to 2025, PPG plans to assess the necessityof price increases in response to ongoing macroeconomic pressures. The company aims for organic sales growth in the low single digits, particularly benefiting from strong demand in aerospace coatings and infrastructure spending in transportation solutions.
The annual report detailed the performance of PPG's three main business segments. The Architectural Coatings segment reported sales of USD 3.921 billion in 2024, down 2.5% compared to the previous year, while the Performance Coatings segment grew to USD 5.237 billion, reflecting a 2% increase. However, the Industrial Coatings segment faced a more significant challenge, with sales declining 5.7% to USD 6.687 billion.
On the workforce front, PPG reduced its global employee count to approximately 46,000, down from 53,000 in the previous year, primarily due to the divestiture of its North American architectural coatings business. This strategic move is part of PPG's efforts to streamline operations and enhance profitability.
Looking for chemical products? Let suppliers reach out to you!
2026-07-20
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
Recommend Reading
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
O Boticário Enters the US Market with Mushroom Fragrance Innovation
-
Bullish Support, Palm Oil Prices Surge After the Holiday
-
Cabot Corporation to Acquire Mexico Carbon Manufacturing
-
Business Society: Formic Acid Price Center Moves Lower, Entering a Consolidation Phase
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal